A detailed history of Soltis Investment Advisors LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Soltis Investment Advisors LLC holds 2,164 shares of NVO stock, worth $183,940. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,164
Holding current value
$183,940
% of portfolio
0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 18, 2024

BUY
$119.07 - $145.42 $257,667 - $314,688
2,164 New
2,164 $257,000
Q1 2024

Apr 29, 2024

BUY
$102.11 - $135.92 $165,213 - $219,918
1,618 New
1,618 $207,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Soltis Investment Advisors LLC Portfolio

Follow Soltis Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soltis Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Soltis Investment Advisors LLC with notifications on news.